In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
By Andrew M. Seaman New York (Reuters Health) – Women with lung cancer who ate the most soy before their diagnosis might live a little longer than those…
Sean Ahrens, co-founder of Crohnology, discusses how he brought a community of Crohn’s and Colitis patients together to share their collective knowledge and track their disease. Sean was diagnosed…
An estimated 20 to 40 percent of cancer patients receiving certain types of chemotherapy treatments may experience debilitating pain. The pain can cause a number of symptoms including…
NEW YORK (Reuters Health) – Environmental factors appear to influence the incidence of papillary thyroid microcarcinomas (PTMCs), according to a comparison of epidemiologic data from Sicily and the…
Mark Rosenberg, MD, MPP, President of The Task Force for Global Health, gives physicians tips on how they can play a role in reducing gun violence in their…
Rafael Yuste, MD, PhD, Professor of Neuroscience at Columbia University, discusses the many ways that the Brain Activity Map will fundamentally change medicine and neuroscience. Whether it’s pinpointing specific neural…
NEW YORK (Reuters Health) – In a randomized controlled trial, the anti-CA-125 vaccine abagovomab did not prolong survival in patients with ovarian cancer in first remission — despite…
What will it take to complete the Brain Activity Map? Rafael Yuste, MD, PhD, Professor of Neuroscience at Columbia University, talks about the latest tools being developed to measure…
NEW YORK (Reuters Health) – Even without conventional conditioning and cytoxic chemotherapy, an allogeneic hematopoietic cell transplant (HCT) can have a substantial benefit in patients with advanced hematologic…
Rafael Yuste, MD, PhD, Professor of Neuroscience at Columbia University, discusses the research goals of the brain activity map project. He explains the purpose of this ground breaking…
